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Abstract
Background: Competitive interactions among bacteria in the respiratory tract microbiota influence which species
can colonize and potentially contribute to pathogenesis of community-acquired pneumonia (CAP). However,
understanding of the role of respiratory tract microbiota in the clinical course of pediatric CAP is limited.
Methods: We sought to compare microbiota profiles in induced sputum and nasopharyngeal/oropharyngeal
(NP/OP) samples from children and to identify microbiota profiles associated with CAP severity. We used 16S
ribosomal RNA sequencing and several measures of microbiota profiles, including principal component analysis
(PCA), to describe the respiratory microbiota in 383 children, 6 months to <18 years, hospitalized with CAP. We
examined associations between induced sputum and NP/OP microbiota profiles and CAP severity (hospital length
of stay and intensive care unit admission) using logistic regression.
Results: Relative abundance of bacterial taxa differed in induced sputum and NP/OP samples. In children 6 months to
< 5 years, the sputum PCA factor with high relative abundance of Actinomyces, Veillonella, Rothia, and Lactobacillales
was associated with decreased odds of length of stay ≥ 4 days [adjusted odds ratio (aOR) 0.69; 95 % confidence
interval (CI) 0.48–0.99]. The sputum factor with high relative abundance of Haemophilus and Pasteurellaceae was
associated with increased odds of intensive care unit admission [aOR 1.52; 95 % CI 1.02–2.26]. In children 5 to < 18 years,
the sputum factor with high relative abundance of Porphyromonadaceae, Bacteriodales, Lactobacillales, and Prevotella
was associated with increased odds of length of stay ≥ 4 days [aOR 1.52; 95 % CI 1.02–2.26]. Taxa in NP/OP samples were
not associated with CAP severity.
Conclusion: Certain taxa in the respiratory microbiota, which were detected in induced sputum samples, are associated
with the clinical course of CAP.
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Background
Community-acquired pneumonia (CAP) is an import-
ant cause of morbidity and mortality in children [1, 2].
Traditional models of CAP pathogenesis have described
this disease as resulting from invasion and growth of a
single pathogen in the lung (e.g., Streptococcus pneumo-
niae as the etiologic agent); and epidemiologic studies
frequently seek to identify a limited number of bacteria
and respiratory viruses as the causative agents of CAP
[3, 4]. However, newer models of CAP pathogenesis
posit that the upper and lower airways are a complex
and connected ecosystem and that CAP occurs as a
consequence of disruptions in respiratory tract homeo-
stasis [5]. Few, if any, culture-independent studies have
examined associations between the clinical course of
CAP in hospitalized children and samples from both
the upper and lower respiratory tract.
CAP results from complex interactions between the
host immune response, the respiratory tract microbiota,
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and CAP-associated pathogens [5–7]. Competitive inter-
actions among bacteria of the upper respiratory tract
microbiota influence which species can colonize the
respiratory tract and potentially contribute to pathogen-
esis of CAP [8–11]. Bacteria within the upper and lower
respiratory tract microbiota can alter host immune re-
sponses and the virulence of CAP pathogens [12–14].
Respiratory virus infection may lead to the overgrowth
of select bacteria in the upper respiratory tract microbiota,
facilitate transition of bacteria into the lower airways, or
promote enhanced replication of bacteria already present
in the lower airways [1, 15–18]. Collectively, these data
suggest that the composition of the respiratory tract
microbiota influences the clinical course of CAP.
The Centers for Disease Control (CDC) Etiology of
Pneumonia in the Community (EPIC) study was a pro-
spective, multi-site, population-based active surveillance
study to determine the incidence and etiology of CAP in
the United States [4]. Nasopharyngeal (NP), oropharyn-
geal (OP), and induced sputum samples were collected
from children at the Memphis, TN site. The value of re-
spiratory tract samples for detection of bacterial CAP
pathogens in children has been debated [19, 20]. Culture
data from induced sputum samples have been shown to
provide useful information in children with pneumonia
[20] and cystic fibrosis [21]. While sputum samples have
limitations, we hypothesized that they would provide
relevant information regarding microbial environment of
the lower airways in children with CAP [20, 22, 23]. Our
overall goal was to describe the respiratory tract micro-
biota in children hospitalized with CAP. Specifically we
sought to 1) use 16S ribosomal RNA (rRNA) microbial
profiling to determine whether microbiota profiles differ
between induced sputum and NP/OP samples from chil-
dren hospitalized with CAP, and 2) identify microbiota
profiles associated with CAP severity as measured by
length of hospital stay (LOS) and intensive care unit
(ICU) admission.
Methods
Study design and participants
Data for the current study were collected at Le Bonheur
Children’s Hospital, the Memphis, TN site of the EPIC
study [4]. The institutional review boards at the University
of Tennessee Health Science Center and the CDC ap-
proved the study. Written informed consent was obtained
from parents or caregivers prior to enrollment and chil-
dren provided assent when age appropriate. This analysis
focused on a convenience sample of children hospitalized
with radiographically confirmed CAP, including only those
who were enrolled in the first two years of the EPIC study,
between January 2010 and December 2011. A detailed de-
scription of the EPIC study methods is provided elsewhere
[4]. We restricted our study population to 383 children
who were ≥ 6 months to < 18 years of age and contrib-
uted an induced sputum, NP, and OP sample. Children
< 6 months were excluded due to differences in the
associated pathogens and severity of CAP in neonates
and very young infants [24].
Sample collection, clinical and epidemiologic data
Induced sputum, NP, and OP samples were collected at
enrollment: 89 % within 24 h of hospital admission and
11 % between 24 and 48 h of hospital admission. Spu-
tum production was induced via inhalation of albuterol
followed by 7 % saline to induce deep cough [20]. Suc-
tioning through the nose or mouth was then used in
children who were too young to expectorate. Trained
staff obtained an NP and an OP swab from each of the
enrolled children.
Sputum samples were plated for culture of CAP associ-
ated bacterial pathogens (e.g., S. pneumoniae, Haemophi-
lus influenzae, Moraxella cattharalis, and Staphylcococcus
aureus) using standard microbiologic methods. Two hun-
dred microliters of the original sputum sample was diluted
in 1 mL of EasyMag lysis buffer and stored at -80 °C until
DNA extraction. DNA extraction of sputum samples was
performed using the Biomerieux NucliSENS EasyMag in-
strument. NP and OP swabs were combined to maximize
detection of respiratory viruses and are hereafter referred
to as NP/OP swabs. DNA was extracted from NP/OP
swabs using the Maxwell® LEV Blood DNA kit (Madison,
WI) with minor modifications; samples were centrifuged
at 7500 rpm for 10 min and the pellet resuspended in
180 μl of lysis solution containing mutanolysin, lysozyme,
and lysostaphin. The sample was incubated for 30 min at
37 °C and then processed according to the manufacturer’s
instructions.
Etiologic data from the EPIC study included results
from diagnostic testing for bacterial pathogens by cul-
ture of blood or other specimens (e.g., pleural fluid) and
PCR of whole blood to identify S. pneumoniae and
group A streptococcus [4]. NP/OP swabs were tested by
PCR using CDC primers for Mycoplasma pneumoniae,
Chlamydophila pneumoniae, and the following respira-
tory viruses: human rhinovirus, respiratory syncytial
virus (RSV), adenovirus, human metapneumovirus, cor-
onavirus (types OC43, 229E, NL63, and HKU1), para-
influenza viruses (types 1–3), and influenza A and B [4].
With the exception of rhinovirus and coronaviruses,
serologic tests were performed for the previously listed
viruses.
Data regarding demographic characteristics, underlying
conditions, and exposures known to alter the composition
of the respiratory microbiota (e.g., prior antibiotic use,
fall/winter season) [10, 25–27] were also obtained in
the EPIC study [4]. Demographic data, environmental
tobacco smoke exposure, and prior antibiotic use data
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were collected via child/caregiver report. Environmen-
tal tobacco smoke exposure was categorized as present
if smoking was allowed in the child’s home. Prior anti-
biotic use was defined as any use of antibiotics prior to
hospitalization for the current CAP episode or chronic
use of antibiotics. Presence of asthma/reactive airway
disease and chronic conditions other than asthma were
determined by child/caregiver report. Chronic condi-
tions other than asthma included congenital heart dis-
ease, chronic lung disease, diabetes, kidney, heart or
liver disorder, immunosuppression, and pre-term birth.
Additional data obtained through medical chart ab-
straction included LOS (defined as the length of time in
days from the admission date, or triage date if applic-
able, to hospital discharge) and ICU admission. Data on
vaccination for H. influenzae type B and S. pneumoniae
were collected via child/caregiver report and verified
primarily by obtaining vaccine records from primary
care physicians and by reviewing vaccine registries. Vac-
cines have been shown to alter the nasopharyngeal flora
[26]. Thus, children were classified as vaccinated for H.
influenzae type B (yes/no) or S. pneumoniae (yes/no) if at
least one vaccine dose was received prior to enrollment
and verified. This study population included older children
who may not have received the pneumococcal vaccine be-
cause they were either born before, or were older than, the
recommended age for vaccination when pneumococcal
conjugate vaccines became available.
Sequencing and processing of 16S rRNA gene
sequence reads
PCR amplification of the 16S rRNA hypervariable region
V4 was performed on extracted DNA samples in dupli-
cate with negative controls using 515 F and 806R bar-
coded primers [28]. Samples were pooled in equimolar
amounts in batches of up to 96 samples. Pooled PCR
products were sent to the Yale Center for Genome Ana-
lysis using the Illumina MiSeq platform [28].
Btrim software was used to sort, trim, and filter low
quality sequences [10, 29]. Cleaned and filtered sequences
were processed using customized analytic pipelines and
open source packages available through the Ribosomal
Database Project (RDP) [10, 11, 30]. Sequence reads were
aligned using the RDP alignment tool. The command line
RDP classifier tool was used for taxonomic assignment
[30]. Sequences were classified in an iterative process.
Taxa were defined by grouping together all sequences be-
longing to the same genus. Sequences that were unclassi-
fied at the genus level were classified and then grouped at
the next lowest taxonomic level.
Characterization of microbiota profiles
We used three different approaches to describe micro-
biota profiles. First, we examined the distribution of the
relative abundance of each taxon more frequent than
0.8 % of the microbial community (n = 22 taxa). The dis-
tributions for relative abundances were highly skewed;
therefore, we identified the top quartile of the distribu-
tion within each age group. Cutoff values for the 75th
percentile are shown in Additional file 1: Table S1. We
then created a binary variable for each sample taxon as
being in the top quartile of the distribution or not. Sec-
ond, we identified individual taxa that were differentially
abundant in groups of samples using linear discriminant
analysis (LDA) effect size (LefSe) [31]. We used 2.0 as
the threshold cutoff value on the logarithmic LDA score
for identifying taxa that differed in abundance between
comparison groups [31]. Taxa within the airway micro-
biota may co-colonize based on similar nutritional re-
quirements or utilization of secondary metabolites [32].
Thus, for our third approach, we used principal compo-
nent analysis (PCA) to examine relationships among the
same 22 taxa identified above. PCA is a statistical
method used to identify groups of correlated variables
within a dataset (e.g., bacterial taxa) [33]. These subsets
of correlated variables are then combined into independ-
ent factors that represent linear relationships among
taxa. The factors are interpreted as reflecting underlying
processes that created the observed associations. We
specified an eigenvalue of one and an orthogonal rota-
tion in the PCA. Taxa with a loading value of at least ±
0.4 were retained and considered taxa of interest for that
factor [10, 11, 33].
Statistical analysis
All analyses were stratified by age categorized as 6 months
to < 5 years and 5 to < 18 years. CAP severity was measured
by 1) LOS ≥ 4 days (yes/no), the 75th percentile of the
distribution of LOS, and 2) ICU admission (yes/no). To ex-
plore associations between measures of microbiota profiles
and CAP severity, we used multivariate logistic regression.
In order to identify potential confounders, we evaluated un-
adjusted associations between individual patient character-
istics and exposures of interest (e.g., taxa identified by LefSe
as differentially abundant between groups) and outcomes
(i.e., LOS or ICU admission) by chi-square test, Fisher’s
exact test, and analysis of variance or paired t-tests as ap-
propriate. Taxa identified by LefSe as differentially present
in the CAP severity groups (LOS < 4 or ≥ 4 days or ICU
admission (yes/no)) were categorized as being in the top
quartile of that taxon’s distribution and included in the
models as a binary variable (yes/no). Factor scores from
PCA were included in models as continuous variables.
Models were adjusted for potential confounders if they
were associated with the exposure and the outcome (P <
0.15) in unadjusted analyses [34]. Variables were removed if
they were not statistically significant (P < 0.05) and if
removal did not change the likelihood ratio by more than
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Demographic and clinical characteristics of the children
hospitalized with CAP are shown in Table 1. Of the 383
children, 68.7 % were 6 months to < 5 years of age and
79.1 % were black. Over half (53.0 %) had a history of
asthma/reactive airway disease and nearly a quarter
(24.0 %) had chronic conditions other than asthma
(Table 1). A history of asthma/reactive airway disease
and ICU admission were more frequent in children 5 to
< 18 years compared to children 6 months to < 5 years
of age. The majority of children received at least one
dose of pneumococcal conjugate vaccine (91.6 %).
Fewer children 5 to < 18 years received at least one
dose of pneumococcal conjugate vaccine compared to
children 6 months to <5 years of age.
Diagnostic testing resulted in detection of S. pneu-
moniae in nine (2.4 %) children and H. influenzae in
one (0.3 %) (Additional file 1: Table S2). One or more
respiratory viruses were identified in 310 (80.9 %) chil-
dren (Additional file 1: Table S2). Rhinovirus and re-
spiratory syncytial virus (RSV) were the two most
common respiratory viruses detected (Additional file
1: Table S2). Subsequent analyses of bacteria and
viruses detected through diagnostic testing were re-
stricted to rhinovirus and RSV due to the low fre-
quency of detection of other CAP pathogens. RSV was
detected more frequently in children 6 months to
<5 years whereas rhinovirus was detected more fre-
quently in children 5 to <18 years (Additional file 1:
Table S2). Sputum culture results were not used for
etiologic diagnosis and are included in Additional file
1: Table S2. S. pneumoniae, H. influenzae and M. cat-
arrhalis were detected more frequently in children
6 months to <5 years than in children 5 to <18 years.
Subsequent analyses were stratified by age group due
to the age difference in prevalence of bacteria and
respiratory viruses in this study population (Additional
file 1: Table S2), and previously described differences
in the prevalence of colonization by potential CAP
pathogens and CAP severity by age [24, 36, 37].
Table 1 Characteristics of 383 children, 6 months to <18 years of age, hospitalized with community-acquired pneumonia
Age group
6 months to <5 years 5 to <18 years
Characteristic N (%) % % P value
Age
6 months to < 5 years 263 (68.7) – –
5 to <18 years 120 (31.3) – –
Race/Ethnicity 0.25
White 47 (12.3) 10.6 15.8
Black 303 (79.1) 79.8 77.5
Other 33 (8.6) 6.1 2.5
Gender 0.43
Female 171 (44.6) 46.0 41.7
Male 212 (55.4) 54.0 58.3
Fall/winter season 225 (58.8) 59.7 56.7 0.58
Environmental tobacco smoke exposurea 44 (11.6) 10.4 14.2 0.29
Medical history
Asthma/reactive airway disease 203 (53.0) 47.9 64.2 0.003
Chronic conditions other than asthma 92 (24.0) 24.0 24.2 0.96
Prior Antibiotics 82 (21.4) 22.4 19.2 0.47
Pneumococcal vaccineb 347 (91.6) 98.5 76.5 <0.0001
Length of stay (days) 0.18
4 or more 105 (27.4) 24.3 34.2
ICU admission 50 (13.0) 9.9 20.0 0.006
Numbers in the columns in each group represent the percent of children with that characteristic in that age group. Bold indicates a significant P value of <0.05
aMissing data for 4 subjects
bReceipt of at least one or more doses prior to enrollment, missing data for 4 subjects
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Comparison of sputum and NP/OP samples
A mean (standard deviation [SD]) of 86,879 (37,698) se-
quence reads were obtained in sputum samples. A mean
of 92,534 (32,060) sequence reads were obtained in NP/
OP samples.
Streptococcus, Moraxella, or Haemophilus was the
dominant taxon in individual sputum samples for the
majority of children 6 months to <5 years and in individ-
ual NP/OP samples for the majority of children of any
age (Table 2 and Additional file 2: Figure S1). In con-
trast, Streptococcus, Prevotella, or Pasteurellaceae was
the dominant taxon in individual sputum samples for
the majority of children 5 to <18 years (Table 2 and
Additional file 2: Figure S1).
LefSe indicated that taxa within sputum and NP/OP sam-
ples differ in their relative abundance. Among children
6 months to <5 years, the relative abundance of seven taxa
was higher in sputum samples and the relative abundance
of 11 taxa was higher in NP/OP samples (Fig. 1a). Among
children 5 to <18 years, the relative abundance of 10 taxa
was higher in sputum samples and the relative abundance
of four taxa was higher in NP/OP samples (Fig. 1b).
Unadjusted associations between individual
characteristics and CAP outcomes
Unadjusted associations between individual characteris-
tics and LOS ≥4 days or ICU admission are shown in
Table 3. In children 6 months to <5 years, the distribu-
tions of patient characteristics and season of enrollment
were similar among those with LOS <4 days and those
with LOS ≥4 days and among those with and without
ICU admission (Table 3). However, RSV was more
frequently detected in children who did not (43.9 %) vs.
children who did (23.1 %) have an ICU admission (P =
0.04) (Table 3). Among children 5 to <18 years, asthma/
reactive airway disease was more frequent in children
with LOS <4 days compared to those with LOS ≥4 days
(73.4 % vs. 46.3 % respectively, P = 0.003) (Table 3). Re-
ceipt of at least one dose of pneumococcal conjugate
vaccine was more frequent in those with LOS <4 days
compared to those with LOS ≥4 days (83.5 % vs. 62.5 %
respectively, P = 0.01) (Table 3).
Adjusted associations between sputum microbiota
profiles and CAP outcomes
Results for all final, adjusted logistic regression models
are given below for each of our methods of describing
microbiota profiles: individual taxa and PCA factors. In
children 6 months to <5 years, final models of the asso-
ciation between microbiota profiles and LOS ≥4 days
were adjusted for asthma/reactive airway disease and
models of the association between microbiota profiles
and ICU admission were adjusted for the presence of
rhinovirus and RSV. In children 5 to <18 years, final
models of the association between microbiota profiles
and LOS ≥4 days vs. < 4 days were adjusted for asthma/
reactive airway disease, chronic conditions other than
asthma, and gender, and models of the association
between microbiota profiles and ICU admission were
adjusted for chronic conditions other than asthma.
Individual taxa in sputum
We identified individual taxa that were differentially
abundant in CAP severity groups using LefSe. We then
evaluated each taxon separately in adjusted models. In
children 6 months to <5 years, high relative abundance
of Actinomyces [aOR 0.29; 95 % confidence interval (CI)
0.12–0.67], Veillonella [aOR 0.40, 95 % CI 0.18–0.86],
and Rothia [aOR 0.33, 95 % CI 0.15–0.75] were individu-
ally associated with decreased odds of LOS ≥4 days. In
children 5 to <18 years, high relative abundance of
Gemella was associated with decreased odds of LOS
≥4 days [aOR 0.05; 95 % CI 0.01–0.39]. There were no
taxa that were individually associated with ICU admis-
sion in adjusted models in either age group.
PCA factors in sputum
We identified four PCA factors in children 6 months to
<5 years and two factors in children 5 to <18 years.
Taxa within each factor and factor loadings are shown
in Table 4. Figure 2 shows the mean proportion of
Table 2 Proportion of children with a given dominant bacterial
taxon by age group, 6 months to <5 years (n = 263) or 5 to
<18 years (n = 120)
6 months to <5 years 5 to <18 years
Sputum NP/OP Sputum NP/OP
Taxa N (%) N (%) N (%) N (%)
Streptococcus sp. 112 (42.6) 188 (71.5) 50 (41.7) 58 (48.3)
Moraxella sp. 60 (22.8) 19 (7.2) 3 (2.5) 30 (25.0)
Haemophilus sp. 36 (13.7) 22 (8.4) 4 (3.3) 10 (8.3)
Prevotella sp. 20 (7.6) 3 (1.1) 38 (31.7) 2 (1.7)
Pasteurellaceae family 16 (6.1) 9 (3.4) 6 (5) 2 (1.7)
Neisseria sp. 7 (2.7) 10 (3.8) 4 (3.3) (0)
Fusobacterium sp. 3 (1.1) (0) 2 (1.7) 1 (0.8)
Veillonella sp. 3 (1.1) 5 (1.9) 2 (1.7) 1 (0.8)
Corynebacterium sp. 1 (0.4) (0) (0) 2 (1.7)
Dolosigranulum sp. 1 (0.4) (0) 1 (0.8) (0)
Leptotrichia sp. 1 (0.4) (0) 1 (0.8) 2 (1.7)
Mycoplasma sp. 1 (0.4) (0) 6 (5) (0)
Rothia sp. 1 (0.4) 2 (0.8) 1 (0.8) 3 (2.5)
Porphyromonadaceae family 1 (0.4) 1 (0.4) 1 (0.8) 5 (4.2)
Actinomyces sp. (0) (0) 1 (0.8) (0)
Gemella sp. (0) 2 (0.8) (0) 1 (0.8)
Bacteroidetes phylum (0) 2 (0.8) (0) 3 (2.5)
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individual taxa that were included in the factor ana-
lysis for subjects 6 months to <5 years grouped by
LOS <4 days or ≥4 days (Fig. 2a) and ICU admission
(Fig. 2b). Factor 1, which contained high relative abun-
dance of Actinomyces,Veillonella, Rothia and Lactoba-
cillales, was associated with decreased odds of LOS of
≥4 days [aOR 0.69; 95 % CI 0.48–0.99]. Factor 3,
which contained high relative abundance of Haemoph-
ilus and Pasteurellacea and low relative abundances of
Streptococcus, was associated with higher odds of ICU
admission [aOR 1.52; 95 % CI 1.02–2.26].
Figure 3 shows the mean proportion of taxa included
in the factor analysis of children ≥5 years grouped by
LOS <4 days or ≥4 days. Prevotella and Streptococcus
were two of the most abundant taxa in children ≥5 years.
Factor 2 contained high relative abundance of Porphyro-
monadaceae, Bacteriodales, Lactobacillales, and Prevo-
tella and low relative abundance of Streptococcus. In
a
b



















LDA score (log 10)NP/OPSputum















LDA score (log 10)NP/OPSputum
Fig. 1 Differences in the abundance of taxa in sputum and nasopharyngeal/oropharyngeal (NP/OP) samples from children 6 months to <5 years
(a) and 5 to <18 years (b). Differences were identified using linear discriminant analysis (LDA) effect size (LefSe). A threshold of 2.0 on the
logarithmic LDA score was used to identify taxa that significantly differed in abundance between sputum and NP/OP samples
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Table 3 Unadjusted associations between individual characteristics [n (%)] of children 6 months to <5 years (n = 263) or 5 to <18 years
(n = 120), hospitalized with community-acquired pneumonia and length of stay (LOS) or intensive care unit (ICU) admission
LOS ICU admission
<4 days ≥ 4 days No Yes
Characteristic N (%) (%) (%) P value (%) (%) P value
Age 6 months to <5 years
Demographic
Race/Ethnicity 0.35 0.64
White 28 (10.6) 10.6 10.9 10.1 15.4
Black 210 (79.8) 81.4 75.0 80.6 73.1
Other 25 (9.5) 8.0 14.1 9.3 11.5
Gender 0.87 0.67
Female 121 (46.0) 45.7 46.9 45.6 50.0
Male 124 (54.0) 54.3 53.1 54.4 50.0
Fall/winter season 157 (59.7) 59.3 60.9 0.82 60.7 50.0 0.29
Environmental tobacco smoke exposure 27 (10.4) 11.8 6.3 0.21 9.9 15.4 0.32
Medical History
Asthma/reactive airway disease 126 (47.9) 44.7 57.8 0.07 46.8 57.7 0.29
Chronic conditions other than asthma 63 (24.0) 22.1 29.7 0.22 23.6 26.9 0.71
Prior antibiotics 59 (22.4) 22.6 21.9 0.90 22.4 23.1 0.93
Pneumococcal vaccinea 256 (98.5) 98.5 98.4 0.97 98.7 96.0 0.29
Respiratory virus positive
RSV 110 (41.8) 42.7 39.1 0.61 43.9 23.1 0.04
Rhinovirus 89 (33.8) 36.2 26.6 0.16 35.4 19.2 0.10
Age 5 to <18 years
Demographic
Race/Ethnicity 0.81 0.73
White 19 (15.8) 16.5 14.6 16.7 12.5
Black 93 (77.5) 76.0 80.5 76.0 83.3
Other 8 (6.7) 7.6 4.9 7.3 4.2
Gender 0.05 0.16
Female 50 (41.7) 35.4 53.7 38.5 54.2
Male 70 (58.3) 64.6 46.3 61.5 45.8
Fall/winter season 68 (56.7) 58.2 53.7 57.3 54.2 0.78
Environmental tobacco smoke exposure 17 (14.2) 15.2 12.2 0.66 14.6 12.5 1.00
Medical History
Asthma/reactive airway disease 77 (64.2) 73.4 46.3 0.003 64.6 62.5 0.85
Chronic conditions other than asthma 29 (24.2) 19.0 34.2 0.07 20.8 37.5 0.09
Prior antibiotics 23 (19.2) 16.5 24.4 0.30 19.8 16.7 0.73
Pneumococcal vaccineb 91 (76.5) 83.5 62.5 0.01 80.2 60.9 0.05
Respiratory virus positive
RSV 13 (10.8) 12.7 7.3 0.37 9.4 16.7 0.30
Rhinovirus 59 (49.2) 55.7 36.6 0.05 46.9 58.3 0.32
aReceipt of at least one or more doses prior to enrollment, missing data for 3 subjects. Bold indicates a significant P value of <0.05
bReceipt of at least one or more doses prior to enrollment, missing data for 1 subject
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children ≥5 years, Factor 2 was associated with increased
odds of a LOS ≥4 days [aOR 1.56; 95 % CI 1.03–2.36].
There were no linear combinations of taxa (PCA factors)
that were significantly associated with ICU admission
(data not shown).
Adjusted associations between NP/OP microbiota profiles
and CAP outcomes
Associations between microbiota profiles in NP/OP
samples and CAP outcomes were evaluated in adjusted
models similar to those described above for sputum
samples.
Individual taxa in NP/OP samples
There were no differentially abundant taxa in NP/OP
samples that were associated with LOS of ≥4 days or
ICU admission in adjusted models (data not shown).
Moreover, none of the individual taxa identified in spu-
tum samples as associated with CAP severity were asso-
ciated with LOS of ≥4 days or ICU admission in
adjusted models when detected in NP/OP samples.
PCA factors in NP/OP samples
We examined microbiota profiles using PCA to identify
relationships among correlated taxa in NP/OP samples.
We identified three factors in children 6 months to
<5 years and two factors in children 5 to <18 years. The
correlated taxa in NP/OP PCA factors (Additional file 1:
Table S4) differed from those identified in sputum sam-
ples (Table 4). There were no NP/OP PCA factors asso-
ciated with CAP outcomes in adjusted models (data not
shown).
Discussion
Historically, researchers have viewed CAP as resulting
from invasion of a single pathogen into the lungs. Re-
cent data including the present analysis suggest that
CAP should be considered as a polymicrobial disease.
We described the association between bacterial taxa
within the respiratory tract microbiota and severity of
CAP. The relative abundance of specific taxa differed in
induced sputum and NP/OP samples from children.
None of the NP/OP measures of microbiota profiles
were associated with CAP severity. In contrast, we iden-
tified individual taxa and three different community pro-
files (factors) in sputum samples that were associated
with CAP severity. These data suggest that 1) induced
sputum samples provide useful information for under-
standing the microbial environment of the respiratory
tract in children hospitalized with CAP, and 2) high rela-
tive abundance and certain combinations of bacteria in
the respiratory tract (e.g., Gram-negative taxa such as
Porphyromonadaceae and Prevotella) may be linked to
the clinical course of CAP in hospitalized children.
Commensals may contribute to the clinical course of
CAP by altering host immune responses or the viru-
lence of potential pathogens in a synergistic or additive
manner [12–14]. Commensals may also produce β-
lactamases that interfere with antibiotic treatment of
respiratory tract infections due to physical proximity
with pathogens [38–40]. In healthy individuals, distinct
microbiota live in different body sites [41]. NP and OP
samples were combined prior to 16S rRNA gene se-
quence analysis and we could not tell whether the taxa
originated from an NP or OP site. Moreover, we cannot
definitively determine whether our sputum samples
contained predominantly lower respiratory tract bac-
teria or upper respiratory tract taxa acquired during
sampling. However, microbiota studies indicate that: 1) the
upper and lower respiratory tract form an interconnected
Table 4 Rotated factor patterns from principal component
analysis (PCA) using proportions of taxa in sputum samples
from children 6 months to <5 years (n = 263) or 5 to <18 years
(n = 120)
Taxa Factor 1 Factor 2 Factor 3 Factor 4
Age 6 months to <5 years
Actinomyces sp. 0.84 0.01 −0.11 −0.09
Veillonella sp. 0.82 0.21 −0.11 −0.12
Rothia sp. 0.76 −0.17 −0.05 0.03
Lactobacillales order 0.64 0.03 −0.10 −0.03
Bacteroidales order 0.08 0.71 −0.10 −0.05
Prevotella sp. 0.30 0.63 −0.05 −0.09
Bacteroidetes phylum −0.16 0.53 −0.21 −0.12
Fusobacterium sp. −0.08 0.49 0.01 −0.03
Porphyromonadaceae family −0.02 0.47 −0.03 0.16
Leptotrichiaceae family 0.08 0.41 0.10 −0.16
Haemophilus sp. −0.19 −0.18 0.68 −0.11
Pasteurellaceae family −0.13 −0.19 0.62 −0.14
Streptococcus sp. 0.05 −0.33 −0.79 −0.25
Corynebacterium sp. −0.03 −0.06 −0.03 0.82
Dolosigranulum sp. −0.12 −0.12 −0.04 0.81
Age 5 to <18 years
Pasteurellaceae family 0.71 −0.09
Haemophilus sp. 0.62 0.00
Neisseria sp. 0.43 −0.14
Rothia sp. −0.47 −0.30
Veillonella sp. −0.57 0.35
Porphyromonadaceae family −0.01 0.69
Bacteroidales order −0.15 0.55
Lactobacillales order −0.36 0.48
Prevotella sp. −0.34 0.47
Streptococcus sp. −0.36 −0.62
Taxa of interest for each factor are in bold
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and complex ecosystem; 2) there is erosion of the zones
of demarcation that differentiate microbiota niches in
diseased compared to healthy states; and 3) non-native
resident taxa frequently and transiently invade inter-
connected body sites within the respiratory tract [5, 23,
42, 43]. Even if our induced sputum samples contained
taxa from the upper respiratory tract, these taxa may
still contribute to the microenvironment in the lung by
production of metabolites and/or by stimulation of sys-
temic host responses [23].
In children 6 months to <5 years, high relative abun-
dance of Actinomyces, Veillonella, and Rothia were asso-
ciated with a decreased odds of LOS ≥4 days each
individually and as a group. Actinomyces and Rothia are
both Gram-positive members of the family Actinomyce-
taceae and Veillonella is a Gram-negative anaerobe.
These taxa are generally considered part of the normal
flora but have been identified in individuals with CAP
[7, 44–46]. High relative abundance of Gram-negative
aerobes Haemophilus and Pasteurellacea and low relative
abundance of Streptococcus were associated with ICU
admission. Non-typeable H. influenzae has frequently
been isolated from children with recurrent CAP [47].
However, H. influenzae was only designated as the eti-
ology of CAP in one child in our study using standard
diagnostic methods.
In children 5 to <18 years, high relative abundance of
Gram-positive anaerobic Gemella species was associ-
ated with decreased odds of LOS ≥4 days. These species
have been associated with pneumonia [48], but a nega-
tive association with severe CAP has not been appreci-
ated previously. PCA analysis showed that high relative
abundance of Porphyromonadaceae, Bacteriodales, Lac-



























































Fig. 2 Mean proportions of taxa grouped by outcomes for subjects 6 months to <5 years of age length of hospital stay (LOS) (a) and intensive
care unit (ICU) admission (b). Taxa of interest identified by principal component analysis (PCA) and associated with community-acquired pneumonia
(CAP) severity are outlined in black
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of Streptococcus were associated with increased odds
of LOS ≥4 days in children ≥5 years. Gram-positive
Lactobacillales (i.e., lactic acid bacteria) are generally
associated with respiratory health [9]. However, Gram-
negative anaerobes including Porphyromonas species,
Bacteroides, and pigmented Prevotella have been de-
tected in cases of aspiration pneumonia and empyema
in children [49]. When these taxa are identified in
children with pneumonia, they are often found in
mixed infections [50]. Prevotella intermedia, an oral
bacterium, was recently shown to have synergistic ef-
fects on S. pneumoniae virulence in murine models of
bacteremic pneumonia [51]. Transtrachial aspiration
followed by culture has been used to identify anaer-
obes in 22–33 % of adults with CAP [52]. Thus,
Gram-negative anaerobes such as Prevotella may play
an important and underappreciated role in the clinical
course of CAP in older children.
A natural question is whether 16S rRNA microbial
profiling adds important information relative to culture-
based protocols. Log transformed relative abundances of
Streptococcus, Heamophilus, Moraxella, and Staphylo-
coccus were significantly associated with identification of
S. pneumoniae, H. influenzae, M. cattharalis, and S. aur-
eus by culture (P = <0.0001 for each species identified by
culture and the corresponding genus level taxon as de-
termined by t-test). Culture of S. aureus was associ-
ated with increased odds of a LOS ≥4 days [aOR 2.48;
95 % CI 1.25–4.90] in children 6 months to <5 years
(Additional file 1: Table S3). Culture of the other bac-
terial pathogens from sputum was not associated with
CAP severity (Additional file 1: Table S3). Thus, our
data suggest that important insights can be gained by
culture-independent analysis of the microbial commu-
nity in sputum samples from children with CAP.
Our study has limitations and any potential causal as-
sociations between the presence of the identified taxa
and CAP severity must be interpreted with caution. In-
duced sputum samples were collected once and we
could not evaluate temporal changes in the microbiota.
Contamination in 16S rRNA microbial profiling and
metagenomic studies has been linked previously to
water- and soil-associated bacteria [53]. We did not se-
quence reagent controls and there was potential for
contamination despite our use of molecular biology
grade water and commercial kits [53]. While we cannot
definitively rule out contamination, we have several
lines of evidence to suggest that our data reflect the
community composition of our clinical samples: 1)
samples were processed in random order, PCR cycles
were kept to a minimum, and PCR reactions were done
in duplicate as recommended by Salter et al. [53]; 2) we
limited our analyses to taxa present in greater than
0.8 % of the microbial community and did not include
rare taxa in our analyses; and 3) our dominant taxa are
consistent with those generally identified in studies of the
human respiratory tract [11, 26, 27]. We did not calculate
alpha and beta diversity measures because of concerns re-
garding the potential for inflation of diversity estimates
due to contamination, PCR amplification, and sequencing
errors on the Illumina platform [54, 55]. Our study popu-

























Fig. 3 Mean proportion of taxa grouped by length of hospital stay (LOS) for subjects 5 to < 18 years. Taxa of interest identified by principal
component analysis (PCA) and associated with LOS ≥4 days are outlined in black
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reactive airway disease and other chronic conditions and
our results may not be generalizable to all hospitalized
children with CAP.
An improved understanding of the role of the respira-
tory microbiota in CAP may yield novel approaches to-
wards prevention or treatment. For example, strategies
for selectively introducing commensals (e.g., microbiota
transplants) to promote optimal levels of biodiversity in
the airways may emerge as effective methods for treating
disease. However, more data are needed regarding the
role of the respiratory microbiota in the clinical course
of CAP before the translational goals of manipulating
the respiratory flora for optimal health and resolution of
disease can be realized. Additional studies are needed to
confirm our findings and to provide mechanistic insights
into relationships between the respiratory tract micro-
biota and CAP. Future data from laboratory and pro-
spective epidemiologic studies will facilitate the design
of effective prevention and treatment strategies for CAP
that maintain the health-associated homeostasis between
children and their commensal flora.
Conclusions
Our data suggest that sputum samples are useful for un-
derstanding the microbial environment in the respiratory
tract during community-acquired pneumonia. Microbiota
profiles associated with severity of pneumonia differed in
children 6 months to <5 years compared to children 5 to
<18 years of age. Specific combinations of bacteria in the
respiratory tract may influence the clinical course of pneu-
monia; high abundance of some bacteria, predominantly
Gram-negative species, was associated with increased se-
verity of pneumonia.
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